Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters

被引:136
作者
Caretti, G
Salsi, V
Vecchi, C
Imbriano, C
Mantovani, R
机构
[1] Univ Milan, Dipartimento Sci Biomol & Biotechnol, I-20133 Milan, Italy
[2] Univ Modena & Reggio Emilia, Dipartimento Biol Anim, I-41100 Modena, Italy
关键词
D O I
10.1074/jbc.M304606200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Regulation of transcription during the cell-cycle is under the control of E2 factors (E2Fs), often in cooperation with nuclear factor Y (NF-Y), a histone-like CCAAT-binding trimer. NF-Y is paradigmatic of a constitutive, ubiquitous factor that pre-sets the promoter architecture for other regulatory proteins to access it. We analyzed the recruitment of NF-Y, E2F1/4/6, histone acetyltransferases, and histone deacetylase (HDAC) 1/3/4 to several cell-cycle promoters by chromatin immunoprecipitation assays in serum-starved and restimulated NIH3T3 cells. NF-Y binding is not constitutive but timely regulated in all promoters tested, being displaced when promoters are repressed. p300 association correlates with activation, and it is never found in the absence of NF-Y, whereas PCAF/hGCN5 is often found before NF-Y association. E2F4 and E2F6, together with HDACs, are bound to repressed promoters, including the G(2)/M Cyclin B2. As expected, an inverse relationship between HDACs association and histones H3/H4 acetylation is observed. Blocking cells in G(1) with the cyclin-dependent kinase 2 inhibitor R-roscovitine confirms that NF-Y is bound to G(1)/S but not to G(2)/M promoters in G(1). These data indicate that following the release of E2Fs/HDACs, a hierarchy of PCAF-NF-Y-p300 interactions and H3-H4 acetylations are required for activation of cell-cycle promoters.
引用
收藏
页码:30435 / 30440
页数:6
相关论文
共 49 条
[1]
Ordered recruitment of chromatin modifying and general transcription factors to the IFN-β promoter [J].
Agalioti, T ;
Lomvardas, S ;
Parekh, B ;
Yie, JM ;
Maniatis, T ;
Thanos, D .
CELL, 2000, 103 (04) :667-678
[2]
CBP/p300 histone acetyl-transferase activity is important for the G1/S transition [J].
Ait-Si-Ali, S ;
Polesskaya, A ;
Filleur, S ;
Ferreira, R ;
Duquet, A ;
Robin, P ;
Vervish, A ;
Trouche, D ;
Cabon, F ;
Harel-Bellan, A .
ONCOGENE, 2000, 19 (20) :2430-2437
[3]
A CONSERVED REGION IN INTRON-1 NEGATIVELY REGULATES THE EXPRESSION OF THE PCNA GENE [J].
ALDER, H ;
YOSHINOUCHI, M ;
PRYSTOWSKY, MB ;
APPASAMY, P ;
BASERGA, R .
NUCLEIC ACIDS RESEARCH, 1992, 20 (07) :1769-1775
[4]
Nutrient regulation of gene expression by the sterol regulatory element binding proteins:: Increased recruitment of gene-specific coregulatory factors and selective hyperacetylation of histone H3 in vivo [J].
Bennett, MK ;
Osborne, TF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6340-6344
[5]
Cyclin A2 transcriptional regulation: Modulation of cell cycle control at the G1/S transition by peripheral cues [J].
Blanchard, JM .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1179-1184
[6]
The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated [J].
Bolognese, F ;
Wasner, M ;
Lange-zu Dohna, C ;
Gurtner, A ;
Ronchi, A ;
Muller, H ;
Manni, I ;
Mossner, J ;
Piaggio, G ;
Mantovani, R ;
Engeland, K .
ONCOGENE, 1999, 18 (10) :1845-1853
[7]
Identification of TATA-binding protein-free TAFII-containing complex subunits suggests a role in nucleosome acetylation and signal transduction [J].
Brand, M ;
Yamamoto, K ;
Staub, A ;
Tora, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18285-18289
[8]
Caretti G, 1999, MOL CELL BIOL, V19, P8591
[9]
NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF [J].
Currie, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1430-1434
[10]
Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex [J].
Farina, A ;
Manni, I ;
Fontemaggi, G ;
Tiainen, M ;
Cenciarelli, C ;
Bellorini, M ;
Mantovani, R ;
Sacchi, A ;
Piaggio, G .
ONCOGENE, 1999, 18 (18) :2818-2827